Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
85.22
Dollar change
+8.17
Percentage change
10.60
%
IndexRUT P/E- EPS (ttm)-0.91 Insider Own8.76% Shs Outstand100.11M Perf Week127.74%
Market Cap8.56B Forward P/E- EPS next Y-1.47 Insider Trans-5.42% Shs Float91.68M Perf Month253.02%
Income-85.89M PEG- EPS next Q-0.28 Inst Own75.05% Short Float13.11% Perf Quarter620.37%
Sales0.00M P/S- EPS this Y-22.99% Inst Trans-0.32% Short Ratio2.36 Perf Half Y523.18%
Book/sh3.48 P/B24.49 EPS next Y-31.72% ROA-31.99% Short Interest12.02M Perf Year648.20%
Cash/sh3.60 P/C23.65 EPS next 5Y40.00% ROE-34.79% 52W Range8.28 - 99.41 Perf YTD357.93%
Dividend Est.- P/FCF- EPS past 5Y-18.89% ROI-24.59% 52W High-14.27% Beta1.06
Dividend TTM- Quick Ratio19.19 Sales past 5Y0.00% Gross Margin- 52W Low929.23% ATR (14)7.71
Dividend Ex-Date- Current Ratio19.19 EPS Y/Y TTM-2.06% Oper. Margin0.00% RSI (14)77.51 Volatility22.42% 11.99%
Employees27 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.10 Target Price99.69
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q3.76% Payout- Rel Volume2.57 Prev Close77.05
Sales Surprise- EPS Surprise1.57% Sales Q/Q- EarningsFeb 07 AMC Avg Volume5.10M Price85.22
SMA20117.87% SMA50204.96% SMA200364.80% Trades Volume13,105,174 Change10.60%
Date Action Analyst Rating Change Price Target Change
Feb-28-24Reiterated Oppenheimer Outperform $46 → $116
May-31-23Resumed ROTH MKM Buy $32
Mar-28-23Reiterated Maxim Group Buy $15 → $25
Mar-17-23Initiated Stifel Buy $22
Jul-29-21Resumed BTIG Research Buy $20
May-25-21Downgrade Raymond James Strong Buy → Outperform $27 → $12
Jun-05-20Initiated BMO Capital Markets Outperform $14
May-05-20Initiated Chardan Capital Markets Buy $15
May-01-20Initiated BTIG Research Buy $9
Jul-16-19Initiated Oppenheimer Outperform $12
Mar-01-24 05:59PM
12:11PM
07:31AM
Feb-29-24 02:21PM
09:00AM
07:45AM Loading…
07:45AM
06:42AM
06:00AM
04:53AM
Feb-28-24 08:50PM
04:56PM
12:23PM
11:23AM
11:01AM
10:00AM
07:30AM Loading…
07:30AM
Feb-27-24 10:15PM
06:01PM
05:35PM
04:22PM
04:19PM
04:06PM
03:50PM
11:21AM
09:47AM
09:39AM
08:15AM
08:14AM
07:22AM
07:13AM
07:03AM Loading…
07:03AM
Feb-21-24 09:21AM
Feb-15-24 11:57AM
Feb-14-24 02:43PM
Feb-10-24 09:02AM
Feb-09-24 02:21AM
Feb-08-24 04:01PM
01:15PM
10:39AM
06:48AM
Feb-07-24 04:47PM
04:05PM
Feb-02-24 02:15AM
Feb-01-24 03:02PM
Jan-31-24 04:05PM
03:01AM
Jan-29-24 02:59AM
Jan-22-24 01:29AM
Jan-19-24 11:01PM
Jan-09-24 11:01PM
Jan-05-24 09:02AM
Jan-02-24 08:09AM
Dec-12-23 08:45AM
Dec-08-23 08:14AM
Dec-03-23 04:14PM
Nov-13-23 04:02PM
Nov-09-23 08:48AM
Nov-04-23 07:30AM
Nov-02-23 04:03PM
Oct-27-23 01:05PM
Oct-26-23 11:22AM
Oct-25-23 06:25PM
04:05PM
Oct-23-23 07:05AM
Oct-19-23 08:45AM
Oct-18-23 04:05PM
10:38AM
10:01AM
Oct-17-23 04:05PM
Oct-11-23 11:11AM
Oct-10-23 04:05PM
Oct-02-23 11:51AM
Sep-07-23 04:05PM
Sep-06-23 07:03AM
Aug-28-23 10:22AM
Aug-17-23 09:31AM
Aug-16-23 07:07PM
Aug-09-23 11:45AM
Aug-08-23 11:45AM
Aug-02-23 11:15AM
Jul-29-23 11:39AM
Jul-27-23 09:51AM
Jul-26-23 04:05PM
Jul-22-23 06:14AM
Jul-19-23 04:05PM
Jul-12-23 10:05AM
Jul-10-23 09:32AM
09:29AM
Jul-07-23 06:32PM
08:00AM
Jul-05-23 08:14PM
Jun-29-23 02:00PM
08:30AM
Jun-27-23 01:53PM
Jun-26-23 11:39PM
Jun-22-23 06:40AM
Jun-20-23 10:15AM
05:50AM
05:25AM
Jun-17-23 09:06AM
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lian BrianPresident & CEOFeb 09Sale29.9045,0001,345,5002,139,882Feb 09 08:59 PM
Lian BrianPresident & CEOFeb 08Option Exercise3.76189,079711,3672,404,882Feb 08 07:40 PM
Rouan Sarah KathrynDirectorFeb 08Option Exercise8.3225,000208,00025,000Feb 08 07:38 PM
Lian BrianPresident & CEOFeb 08Sale26.87269,0797,230,7842,184,882Feb 08 07:40 PM
Rouan Sarah KathrynDirectorFeb 08Sale28.0525,000701,2500Feb 08 07:38 PM
Lian BrianPresident & CEOJan 31Option Exercise1.2385,000104,5502,349,882Jan 31 08:39 PM
Lian BrianPresident & CEOJan 31Sale24.7185,0002,100,7502,264,882Jan 31 08:39 PM
Lian BrianPresident & CEOJan 30Option Exercise1.2335,00043,0502,299,882Jan 30 09:05 PM
Lian BrianPresident & CEOJan 30Sale23.9535,000838,2502,264,882Jan 30 09:05 PM
Rouan Sarah KathrynDirectorJan 19Option Exercise8.3230,000249,60030,000Jan 19 08:35 PM
Rouan Sarah KathrynDirectorJan 19Sale23.0530,000691,5000Jan 19 08:35 PM
ZANTE GREGChief Financial OfficerJan 04Sale17.9015,000268,500180,730Jan 04 09:35 PM
Rowland Charles A JrDirectorMay 16Option Exercise1.0840,00043,20070,000May 18 06:31 PM
MACARTNEY LAWSONDirectorMay 16Option Exercise1.1916,00019,04063,965May 18 06:30 PM
Rowland Charles A JrDirectorMay 16Sale25.0040,0001,000,00030,000May 18 06:31 PM
MACARTNEY LAWSONDirectorMay 16Sale24.0016,000384,00047,965May 18 06:30 PM
Lian BrianPresident & CEOMay 01Sale22.4545,0001,010,2502,197,963May 01 07:03 PM
MACARTNEY LAWSONDirectorApr 24Option Exercise3.3316,00053,28063,965Apr 24 07:31 PM
MACARTNEY LAWSONDirectorApr 24Sale22.0016,000352,06147,965Apr 24 07:31 PM
Lian BrianPresident & CEOApr 19Sale21.4535,000750,7502,242,963Apr 21 07:29 PM
Lian BrianPresident & CEOApr 17Option Exercise2.15125,000268,7502,432,963Apr 18 07:09 PM
MACARTNEY LAWSONDirectorApr 17Option Exercise8.0020,786166,28868,751Apr 18 07:10 PM
Mancini MariannaChief Operating OfficerApr 17Option Exercise13.0712,500163,375300,263Apr 18 07:08 PM
ZANTE GREGChief Financial OfficerApr 17Option Exercise13.077,50098,025156,779Apr 18 07:07 PM
Lian BrianPresident & CEOApr 17Sale20.45155,0003,169,7662,277,963Apr 18 07:09 PM
MACARTNEY LAWSONDirectorApr 17Sale20.0020,786415,72047,965Apr 18 07:10 PM
Mancini MariannaChief Operating OfficerApr 17Sale20.0012,500250,000287,763Apr 18 07:08 PM
ZANTE GREGChief Financial OfficerApr 17Sale20.007,500150,000149,279Apr 18 07:07 PM
Lian BrianPresident & CEOApr 13Option Exercise1.8854,336102,1522,387,299Apr 13 05:14 PM
Lian BrianPresident & CEOApr 13Sale18.4579,3361,463,7492,307,963Apr 13 05:14 PM
ZANTE GREGChief Financial OfficerApr 12Option Exercise5.9941,544249,026190,823Apr 13 05:13 PM
ZANTE GREGChief Financial OfficerApr 12Sale18.0041,544747,792149,279Apr 13 05:13 PM
ZANTE GREGChief Financial OfficerApr 11Option Exercise5.2556,295295,778205,574Apr 13 05:13 PM
ZANTE GREGChief Financial OfficerApr 11Sale18.0056,2951,013,518149,279Apr 13 05:13 PM
ZANTE GREGChief Financial OfficerApr 03Option Exercise7.7730,911240,178178,689Apr 03 07:24 PM
ZANTE GREGChief Financial OfficerApr 03Sale18.0030,911556,398147,778Apr 03 07:24 PM
Lian BrianPresident & CEOApr 03Sale17.8522,000392,7002,232,963Apr 03 07:26 PM
Lian BrianPresident & CEOMar 31Option Exercise9.4967,970645,0352,322,933Apr 03 07:26 PM
Lian BrianPresident & CEOMar 31Sale17.4567,9701,186,0762,254,963Apr 03 07:26 PM
ZANTE GREGChief Financial OfficerMar 30Option Exercise7.2993,750683,482278,807Apr 03 07:24 PM
Lian BrianPresident & CEOMar 30Option Exercise2.42135,382327,8382,408,345Apr 03 07:26 PM
Mancini MariannaChief Operating OfficerMar 30Option Exercise8.1236,100293,122297,995Apr 03 07:22 PM
Lian BrianPresident & CEOMar 30Sale17.16153,3822,632,5162,254,963Apr 03 07:26 PM
ZANTE GREGChief Financial OfficerMar 30Sale17.00131,0292,227,821147,778Apr 03 07:24 PM
Mancini MariannaChief Operating OfficerMar 29Option Exercise9.1315,000136,950303,137Mar 30 09:04 PM
Mancini MariannaChief Operating OfficerMar 29Sale16.0041,242659,872261,895Mar 30 09:04 PM
Mancini MariannaChief Operating OfficerMar 28Option Exercise2.37167,427397,193484,700Mar 30 09:04 PM
Mancini MariannaChief Operating OfficerMar 28Sale15.00196,5632,948,445288,137Mar 30 09:04 PM